ACC Quality Summit Virtual to Showcase Latest Quality Improvement Research, Innovations

Abstract presentations to demonstrate how to effectively translate data, quality programs into achieving quality care

The American College of Cardiology will host the ACC Quality Summit Virtual, Sept. 29 – Oct. 1, 2021. The conference is designed to enhance the knowledge and competency of the entire care team—from clinicians and administrators to quality improvement professionals—to enable them to effectively translate data and quality programs into achieving quality care in their hospitals and health systems.

Over the three-day meeting, sessions will take place across three virtual channels. Some key sessions to watch include:

  • The New Normal: Innovative Approaches to Managing and Measuring Your Accreditation and Registry Workforce
  • The Economics of Accreditation
  • “Selling Quality”…Articulating the Value Proposition and ROI of CV Registries and Accreditation

Special presentations include the opening keynote by Cheryl Pegus, MD, MPH, FACC, Walmart’s executive vice president of health and wellness, on innovation in health care and the Ralph G. Brindis Lecture by ACC Past President Pamela S. Douglas, MD, MACC, addressing the breadth of science unearthed through NCDR data in promoting quality care and more.

J. Douglas Kirk, MD, FACC, chief medical officer at UC Davis Medical Center, will be honored as the 2021 Ray Bahr Award of Excellence winner. The award is named for Raymond Bahr, MD, and is presented annually to an individual who demonstrates extraordinary excellence, vision and leadership in advancing health care.

Abstracts

The ACC Quality Summit Virtual will also feature more than 90 ePosters highlighting quality improvement projects globally. All ACC Quality Summit Virtual abstracts are embargoed until Wednesday, Sept. 29, 2021 at 9 a.m. ET. To obtain media registration for the conference or access to embargoed media information, please contact ACC Associate Director, Media Relations Katie Glenn at kglenn@acc.org.

Notable presentations and ePosters include:

  • Augmenting Patient-Physician Care Team Interactions Through a Proper Introduction
  • Prescription Cancellation Notifications via EMR to Reduce Safety
  • An Inpatient Multidisciplinary Approach to Improve Smoking Cessation in Patients Hospitalized with Cardiovascular Disease

For more information visit, https://cvquality.acc.org/acc-quality-summit.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.